TRLS.LSE Trellus Health plc
- Market cap
- GBX 516K
- P/E
- -
- P/B
- 0.08x
- ROE
- -137.7%
- Dividend yield
- -
- Fundamental score
- -
Ratios use the latest price and the current fiscal year annualized from 1 quarter up to Jun 2025.
Is TRLS.LSE undervalued?
Graham numberThe Graham number of Trellus Health plc cannot be estimated reliably (it needs positive earnings and book value).
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
Trellus Health plc fundamental analysis
No fundamental analysis for Trellus Health plc yet.
Trellus Health plc stock price
Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.
About Trellus Health plc
Trellus Health plc provides digital chronic condition management solutions for employers and health plans. The company offers GRITT resilience-based methodology; and TrellusElevate, a HIPAA-compliant technology platform for remote telemedicine care. Its platform provides support for managing inflammatory bowel disease, including Crohn's Disease and ulcerative colitis. The company was incorporated in 2020 and is headquartered in White Plains, New York.
Full company profileTrellus Health plc financial statements
2025 annualized: Fiscal year 2025 is not finished. Income statement and cash flow are annualized from 1 quarter up to Jun 30, 2025, the balance sheet is the latest quarter. Figures change when the annual report is published.
Trellus Health plc annual financial statements
| Item | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 Anlz |
|---|---|---|---|---|---|---|
| Income Statement | ||||||
| Revenue | - | 25.0K | 18.0K | 19.0K | 114K | 1.18M |
| Gross Profit | - | 25.0K | 18.0K | 19.0K | 114K | 1.18M |
| Operating Income | -1.52M | -5.90M | -8.81M | -6.80M | -8.03M | -12.1M |
| EBITDA | -1.52M | -5.87M | -8.27M | -5.85M | -7.16M | -10.3M |
| Net Income | -1.52M | -5.90M | -8.81M | -6.34M | -7.78M | -12.0M |
| EPS | -0.02 | -0.04 | -0.05 | -0.04 | -0.05 | -0.07 |
| Balance Sheet | ||||||
| Total Assets | 4.37M | 36.8M | 25.9M | 20.3M | 12.1M | 9.22M |
| Total Liabilities | 122K | 1.52M | 822K | 786K | 371K | 513K |
| Shareholders' Equity | 4.25M | 35.3M | 25.1M | 19.5M | 11.8M | 8.71M |
| Cash & Short-term Investments | 3.68M | 32.0M | 19.1M | 12.2M | 4.34M | 1.57M |
| Cash Flow | ||||||
| Operating Cash Flow | -1.30M | -4.77M | -8.62M | -5.27M | -7.32M | -10.1M |
| Capital Expenditure | 24.0K | 3.72M | 2.91M | 2.35M | 540K | 0.00 |
| Free Cash Flow | -1.32M | -8.49M | -11.5M | -7.63M | -7.86M | -10.1M |
| Ratios | ||||||
| ROE | -35.9% | -16.7% | -35.1% | -32.5% | -66.1% | -137.7% |
| ROA | -34.9% | -16.0% | -34.0% | -31.2% | -64.1% | -130.0% |
| Net Profit Margin | - | -23,608.0% | -48,944.4% | -33,363.2% | -6,826.3% | -1,015.9% |
What these items mean
- Revenue
- Total sales of goods and services in the period.
- Gross Profit
- Revenue minus the direct cost of producing what was sold.
- Operating Income
- Profit from the core business after operating expenses.
- EBITDA
- Earnings before interest, taxes, depreciation and amortization.
- Net Income
- Profit left for shareholders after all expenses, interest and taxes.
- EPS
- Net income divided by shares outstanding.
- Total Assets
- Everything the company owns.
- Total Liabilities
- Everything the company owes.
- Shareholders' Equity
- Assets minus liabilities: the book value that belongs to shareholders.
- Cash & Short-term Investments
- Cash and investments that can be turned into cash quickly.
- Operating Cash Flow
- Cash generated by the core business.
- Capital Expenditure
- Cash spent on property, plant and equipment.
- Free Cash Flow
- Operating cash flow minus capital expenditure: cash left for dividends, buybacks or debt repayment.
- ROE
- Return on equity: net income divided by shareholders' equity.
- ROA
- Return on assets: net income divided by total assets.
- Net Profit Margin
- Net income as a share of revenue.
Trellus Health plc dividends
Trellus Health plc has not paid dividends in the last 5 fiscal years.
Who owns Trellus Health plc
- Insiders 16.36%
- Institutions 4.11%
- Public & others 79.53%
- Shares outstanding 430M
- Free float 141M
Trellus Health plc company profile
- Company name
- Trellus Health plc
- Ticker
- TRLS.LSE
- Exchange
- London Exchange
- Sector
- Healthcare
- Industry
- Health Care Equipment & Supplies
- Employees
- 18
- Fiscal year end
- December
- Address
- 44 South Broadway, White Plains, NY, United States, 10601
- Phone
- 800 866 4165
- Website
- trellushealth.com
About Trellus Health plc
Trellus Health plc provides digital chronic condition management solutions for employers and health plans. The company offers GRITT resilience-based methodology; and TrellusElevate, a HIPAA-compliant technology platform for remote telemedicine care. Its platform provides support for managing inflammatory bowel disease, including Crohn's Disease and ulcerative colitis. The company was incorporated in 2020 and is headquartered in White Plains, New York.
Trellus Health plc management
6- Dr. Marla Cindy Dubinsky M.D.Co-Founder, CEO & Director
- Dr. Laurie Keefer Ph.D.Co-Founder & Chair of Scientific Advisory Board
- Ms. Joy Bessenger B.A.Chief Financial Officer
- Ms. Kathleen WilliamsChief Operating & Innovation Officer
- Ms. Amy MurphyDirector of Human Resources
- Leah Conley M.B.A.Head of Global Market Access - Travere Therapeutics & Member of Scientific Advisory Board